GUSB | | | | 0 | 0 |
H1-2 | | | | 0 | 0 |
H2AX | | | | 0 | 0 |
H2BC5 | | | | 0 | 0 |
H3-3A | | | | 0 | 0 |
H3-3B | | | | 0 | 0 |
H3-4 | | | | 0 | 0 |
H3C1 | | | | 0 | 0 |
H3C10 | | | | 0 | 0 |
H3C11 | | | | 0 | 0 |
H3C13 | | | | 0 | 0 |
H3C14 | | | | 0 | 0 |
H3C2 | | | | 0 | 0 |
H3C3 | | | | 0 | 0 |
H3C4 | | | | 0 | 0 |
H3C6 | | | | 0 | 0 |
H3C7 | | | | 0 | 0 |
H3C8 | | | | 0 | 0 |
H3F3A | 骨巨细胞瘤,弥漫性固有桥脑胶质瘤,多形性胶质母细胞瘤,小儿低级别胶质瘤(PLGG)。 | | | 3 | 5 |
H3F3B | 软骨母细胞瘤 | | | 1 | 1 |
H3f3c | | | | 0 | 0 |
HAPLN1 | | | | 0 | 0 |
HAUS2 | | | | 0 | 0 |
HAUS6 | | | | 0 | 0 |
HAVCR2 | 非小细胞肺癌 | PD-1 Inhibitor,TIM-3 Inhibitor, | | 1 | 2 |
HCAR2 | | | | 0 | 0 |
HCK | | | | 0 | 0 |
HCLS1 | | | | 0 | 0 |
HCN1 | | | | 0 | 0 |
HDAC1 | | | | 0 | 0 |
HDAC2 | 肾细胞癌 | 艾贝司他,帕唑帕尼,培唑帕尼, | | 1 | 1 |
HDAC3 | | | | 0 | 0 |
HDAC4 | | | | 0 | 0 |
HDAC6 | | | | 0 | 0 |
HDAC7 | | | | 0 | 0 |
HDAC8 | | | | 0 | 0 |
HDAC9 | | | | 0 | 0 |
HECW1 | | | | 0 | 0 |
HERC2 | | | | 0 | 0 |
HES1 | | | | 0 | 0 |
HEY1 | | | | 0 | 0 |
HFE | | | | 0 | 0 |
HGF | 多形胶质母细胞瘤 | SGX523, | | 1 | 1 |
HIF1A | 结直肠癌,胰腺腺癌,肾细胞癌,肉瘤 | 帕唑帕尼,培唑帕尼, | | 3 | 4 |
HIP1 | | | | 0 | 0 |
HIST1H1C | | | | 0 | 0 |
HIST1H1D | | | | 0 | 0 |
HIST1H1E | | | | 0 | 0 |
Hist1h2ac | | | | 0 | 0 |
Hist1h2al | | | | 0 | 0 |
Hist1h2bc | | | | 0 | 0 |
HIST1H2BD | | | | 0 | 0 |
Hist1h2bo | | | | 0 | 0 |
HIST1H3A | | | | 0 | 0 |
HIST1H3B | | | | 0 | 0 |
HIST1H3C | | | | 0 | 0 |
HIST1H3D | | | | 0 | 0 |
HIST1H3E | | | | 0 | 0 |
HIST1H3F | | | | 0 | 0 |
HIST1H3G | | | | 0 | 0 |
HIST1H3H | | | | 0 | 0 |
HIST1H3I | | | | 0 | 0 |
HIST1H3J | | | | 0 | 0 |
HIST1H4I | | | | 0 | 0 |
HIST2H3C | | | | 0 | 0 |
HIST2H3D | | | | 0 | 0 |
HIST3H3 | | | | 0 | 0 |
HLA-A | | | | 0 | 0 |
HLA-B | | | | 0 | 0 |
HLA-C | 结直肠癌 | Adoptive T-cell Transfer, | | 1 | 1 |
HLA-DRA | 皮肤黑色素瘤 | 阿特朱单抗,阿替利珠单抗,纳武单抗(纳武利尤单抗),派姆单抗(帕博利珠单抗), | | 1 | 1 |
HLA-DRB1 | | | | 0 | 0 |
HLF | | | | 0 | 0 |
HMBS | | | | 0 | 0 |
HMCN1 | | | | 0 | 0 |
HMOX1 | 肾细胞癌 | 索拉非尼,舒尼替尼, | | 1 | 1 |
HNF1A | | | | 0 | 0 |
HNF1B | | | | 0 | 0 |
HNF4A | | | | 0 | 0 |
HNRNPH1 | | | | 0 | 0 |
HOXA11 | | | | 0 | 0 |
HOXA13 | | | | 0 | 0 |
HOXA3 | | | | 0 | 0 |
HOXA9 | | | | 0 | 0 |
HOXB13 | 前列腺癌 | | | 1 | 2 |
HOXC13 | | | | 0 | 0 |
HOXD11 | | | | 0 | 0 |
HOXD13 | | | | 0 | 0 |
HRAS | 癌症,结直肠癌,滤泡性甲状腺癌,头颈癌,非小细胞肺癌,皮肤鳞状细胞癌,甲状腺癌 | AZD8055,比美替尼、贝美替尼,西妥昔单抗,EGFR Inhibitor,厄洛替尼,依维莫司,PD0325901,司美替尼,维莫非尼, | | 10 | 15 |
HRH2 | | | | 0 | 0 |
HSD17B3 | | | | 0 | 0 |
HSD17B4 | | | | 0 | 0 |
HSD3B1 | | | | 0 | 0 |
HSD3B2 | | | | 0 | 0 |
HSP90AA1 | | | | 0 | 0 |
HSP90AB1 | | | | 0 | 0 |
HSPA1B | | | | 0 | 0 |
HSPA4 | | | | 0 | 0 |
HSPA5 | 结直肠癌 | | 氟尿嘧啶, | 1 | 1 |
HSPA8 | | | | 0 | 0 |
HSPB1 | 胰腺导管腺癌 | | 吉西他滨, | 1 | 1 |
HSPD1 | | | | 0 | 0 |
HSPH1 | 结直肠癌,胃腺癌 | | 氟尿嘧啶,顺铂,奥沙利铂, | 2 | 3 |
HTR1A | | | | 0 | 0 |
HUWE1 | | | | 0 | 0 |
HYOU1 | | | | 0 | 0 |
Iars | | | | 0 | 0 |
Ick | | | | 0 | 0 |
ICOSLG | | | | 0 | 0 |
ID2 | | | | 0 | 0 |
ID3 | | | | 0 | 0 |
IDH1 | 急性髓性白血病,间变性少突胶质瘤,星形细胞瘤,脑胶质瘤,神经节胶质瘤,多形胶质母细胞瘤,肝内胆管癌,恶性胶质瘤,骨髓增生异常综合征,胰腺导管腺癌。 | AG-120,AGI-5198,BAY 1436032,贝伐单抗,Bis-2-[5-(phenylacetamide)-1,帕纳替尼/普纳替尼/波纳替尼,4-thiadiazol-2-yl]ethyl Sulfide,Bis-2-(5-phenylacetamido-1,舒尼替尼,4-thiadiazol-2-yl)ethyl Sulfide,西妥昔单抗,达沙替尼,GSK321,Tibsovo,奥拉帕利,替莫唑胺, | | 7 | 40 |
IDH2 | 急性髓性白血病,星形细胞瘤,脑胶质瘤,多形性胶质母细胞瘤,骨髓增生异常综合征,外周T细胞淋巴瘤 | 恩西地平, | | 4 | 18 |
IDO1 | | | | 0 | 0 |
IDO2 | | | | 0 | 0 |
IFITM1 | | | | 0 | 0 |
IFITM3 | | | | 0 | 0 |
IFNAR1 | | | | 0 | 0 |
IFNAR2 | | | | 0 | 0 |
IFNG | | | | 0 | 0 |
IFNGR1 | | | | 0 | 0 |
IFNGR2 | | | | 0 | 0 |
IFNL3 | | | | 0 | 0 |
IGF1 | | | | 0 | 0 |
IGF1R | 非小细胞肺癌 | 吉非替尼,IGF1R Monoclonal Antibody, | | 2 | 2 |
IGF2 | 卵巢癌,胰腺腺癌,前列腺癌 | 卡巴他赛,Ganitumab,Linsitinib, | 多西他赛, | 1 | 4 |
IGF2R | | | | 0 | 0 |
IGFL3 | | | | 0 | 0 |
IGLL5 | | | | 0 | 0 |
IGSF10 | | | | 0 | 0 |
IKBKB | | | | 0 | 0 |
IKBKE | | | | 0 | 0 |
IKZF1 | 急性淋巴细胞白血病,小儿B细胞淋巴细胞白血病,前体B淋巴细胞淋巴瘤/白血病 | | | 2 | 6 |
IKZF2 | | | | 0 | 0 |
IKZF3 | | | | 0 | 0 |
IL10 | | | | 0 | 0 |
IL1RAPL1 | | | | 0 | 0 |
IL21R | | | | 0 | 0 |
IL2RB | 小儿B细胞急性淋巴细胞白血病 | | | 1 | 1 |
IL6 | | | | 0 | 0 |
IL6R | | | | 0 | 0 |
IL6ST | | | | 0 | 0 |
IL7R | 小儿B淋巴细胞白血病,T细胞急性淋巴细胞白血病 | | | 3 | 3 |
IMPG1 | | | | 0 | 0 |
ING1 | | | | 0 | 0 |
INHA | | | | 0 | 0 |
INHBA | | | | 0 | 0 |
INPP4A | | | | 0 | 0 |
INPP4B | | | | 0 | 0 |
INPP5D | | | | 0 | 0 |
INPPL1 | | | | 0 | 0 |
INSR | | | | 0 | 0 |
INSRR | | | | 0 | 0 |
IP6K1 | | | | 0 | 0 |
IPO7 | | | | 0 | 0 |
IQCJ | | | | 0 | 0 |
IRAK1 | | | | 0 | 0 |
IRF1 | | | | 0 | 0 |
IRF2 | | | | 0 | 0 |
IRF4 | | | | 0 | 0 |
IRF6 | | | | 0 | 0 |
IRF8 | | | | 0 | 0 |
IRS1 | | | | 0 | 0 |
IRS2 | 结直肠癌 | BMS-754807, | | 1 | 1 |
ITGAL | | | | 0 | 0 |
ITGB2 | | | | 0 | 0 |
ITGB3 | | | | 0 | 0 |
ITK | | | | 0 | 0 |
ITPA | | | | 0 | 0 |
ITPR2 | | | | 0 | 0 |
ITSN1 | | | | 0 | 0 |
JAK1 | 结肠癌,肝细胞癌,非小细胞肺癌,黑色素瘤,皮肤黑色素瘤 | Enzastaurin,派姆单抗(帕博利珠单抗),芦可替尼/鲁索利替尼/鲁索替尼, | | 5 | 5 |
JAK2 | B细胞成人急性淋巴细胞白血病,骨髓癌,慢性髓细胞白血病,血液癌,淋巴细胞白血病,黑色素瘤,小儿B细胞急性淋巴细胞白血病,小儿B细胞淋巴细胞白血病,真性红细胞增多症,皮肤黑色素瘤 | Pegylated IFN-alpha-2a,派姆单抗(帕博利珠单抗),芦可替尼/鲁索利替尼/鲁索替尼,Fedratinib, | | 7 | 14 |
JAK3 | 肺腺癌,T细胞急性淋巴细胞白血病 | 阿特朱单抗,阿替利珠单抗,托法替尼, | | 3 | 3 |
JARID2 | | | | 0 | 0 |
JMJD1C | | | | 0 | 0 |
JUN | 结直肠癌 | 厄贝沙坦, | | 1 | 1 |
KALRN | | | | 0 | 0 |
KAT6A | | | | 0 | 0 |
KAT6B | | | | 0 | 0 |
KCNA4 | | | | 0 | 0 |
KCND2 | | | | 0 | 0 |
KCNJ2 | | | | 0 | 0 |
KCNJ3 | | | | 0 | 0 |
KCNJ5 | | | | 0 | 0 |
KCNQ2 | | | | 0 | 0 |
KCNT2 | | | | 0 | 0 |
KDM2B | | | | 0 | 0 |
KDM3B | | | | 0 | 0 |
KDM4C | | | | 0 | 0 |
KDM5A | | | | 0 | 0 |
KDM5C | 肾细胞癌 | 依维莫司,舒尼替尼, | | 1 | 1 |
KDM5D | | | | 0 | 0 |
KDM6A | 急性淋巴细胞白血病 | | | 1 | 1 |
KDR | 血管肉瘤,乳腺血管肉瘤,结直肠癌 | 帕唑帕尼,培唑帕尼,瑞戈非尼,索拉非尼,舒尼替尼, | | 5 | 5 |
KEAP1 | | | | 0 | 0 |
KEL | | | | 0 | 0 |
KIAA1210 | | | | 0 | 0 |
KIAA1217 | | | | 0 | 0 |
KIAA1524 | 胰腺导管腺癌 | | 吉西他滨, | 2 | 2 |
KIAA1549 | | | | 0 | 0 |
KIF1B | | | | 0 | 0 |
KIF23 | 肝细胞癌 | | | 1 | 1 |
KIF2B | | | | 0 | 0 |
KIF5B | | | | 0 | 0 |
KIR3DX1 | | | | 0 | 0 |
KIT | 肢端扁桃体黑色素瘤,急性髓系白血病,急性早幼粒细胞白血病,癌症,慢性白血病,慢性髓系白血病,结肠印戒腺癌,子宫内膜癌,胃肠道间质瘤,胃肠道系统癌,肺腺癌,肺癌,非小细胞肺癌,恶性肛门梅尔异常瘤,黑色素瘤,粘膜黑色素瘤,鼻腔未分化癌,实体瘤,全身肥大细胞增多症,胸腺癌,胸腺鳞状细胞癌 | 达沙替尼,博舒替尼,克唑替尼,达沙替尼,Gleevec,伊马替尼,Imatinib Mesylate,米哚妥林,坦度替尼,尼洛替尼,PD-180970,Pictilisib,帕纳替尼/普纳替尼/波纳替尼,瑞戈非尼,司美替尼,索拉非尼,舒尼替尼,舒尼替尼, | | 87 | 329 |
KITLG | | | | 0 | 0 |
KLB | | | | 0 | 0 |
KLC1 | | | | 0 | 0 |
KLF4 | | | | 0 | 0 |
KLF5 | | | | 0 | 0 |
KLF6 | | | | 0 | 0 |
KLHL1 | | | | 0 | 0 |
KLHL6 | | | | 0 | 0 |
KLK1 | | | | 0 | 0 |
KLLN | 乳腺癌,肾细胞癌 | | | 1 | 2 |
KMT2A | 急性髓性白血病 | | | 1 | 1 |
KMT2B | | | | 0 | 0 |
KMT2C | 乳腺癌 | Anastrozole,依西美坦,来曲唑片, | | 2 | 2 |
KMT2D | 滤泡性淋巴瘤,歌舞伎综合征 | AR-42, | | 2 | 2 |
KMT2E | | | | 0 | 0 |
KMT5A | | | | 0 | 0 |
KNSTRN | | | | 0 | 0 |
KPNA4 | | | | 0 | 0 |
KPNB1 | | | | 0 | 0 |
KRAS | 急性白血病,癌症,慢性骨髓单核细胞白血病,透明细胞肉瘤,结肠癌,结直肠癌,子宫内膜癌,上皮性卵巢癌,毛细胞白血病,头颈部鳞状细胞癌,肝细胞癌,肺腺癌,肺癌,非小细胞肺癌肿瘤,肺鳞状细胞癌,淋巴瘤,黑色素瘤,多发性骨髓瘤,骨髓瘤,卵巢癌,胰腺腺癌,胰腺癌,胰腺导管癌,毛细胞星形细胞瘤,腹膜假黏液瘤,罗莎多夫曼病,皮肤黑色素瘤,皮肤鳞状细胞癌,甲状腺癌,甲状腺癌D癌,外分泌胰腺肿瘤 | 玻玛西林,玻玛西尼,Adoptive T-cell Transfer,阿法替尼,司美替尼,ARS-1620,ARS-853,阿特朱单抗,阿替利珠单抗,AZD5438,AZD8186,Refametinib,贝伐单抗,Dactolisib,比美替尼、贝美替尼,BMS-754807,西妥昔单抗,Chemotherapy,考比替尼,克唑替尼,达拉非尼,达沙替尼,Decitabine,EGFR Inhibitor,康奈非尼,厄洛替尼,Fluorouracil,G-573,GDC-0623,吉非替尼,GO-203-2C,IMO,伊沙佐米,Leucovorin,玻玛西林,玻玛西尼,MEK Inhibitor,马法兰,米尔法兰,MK-2206,纳武单抗(纳武利尤单抗),Oxaliplatin (JAN/USAN/INN),哌柏西利,帕博西尼,帕博西林,帕尼单抗,PD0325901,哌柏西利,帕博西尼,帕博西林,派姆单抗(帕博利珠单抗),PI103,PI3K Inhibitor,R1507,RAF265,Refametinib,瑞戈非尼,Ridaforolimus,RO4987655,SCH772984,司美替尼,Small Molecule Inhibitor,索拉非尼,舒尼替尼,西罗莫司,曲美替尼,维莫非尼, | 卡铂,顺铂,多西他赛,反法尼基硫代水杨酸,FOLFOX4方案,吉西他滨,伊立替康,奥沙利铂,紫杉醇,培美曲塞,沙利雷塞, | 35 | 397 |
KRT18 | 前列腺癌 | | | 1 | 1 |
KRTAP5-5 | | | | 0 | 0 |
L3MBTL1 | | | | 0 | 0 |
LAG3 | 雌激素受体阴性乳腺癌 | | | 1 | 1 |
LAMA2 | | | | 0 | 0 |
LAMA3 | | | | 0 | 0 |
LASP1 | | | | 0 | 0 |
LATS1 | | | | 0 | 0 |
LATS2 | | | | 0 | 0 |
LCK | | | | 0 | 0 |
LCP1 | | | | 0 | 0 |
LDLR | | | | 0 | 0 |
LEF1 | | | | 0 | 0 |
LEPR | 脑膜瘤 | | | 1 | 1 |
LGALS8 | | | | 0 | 0 |
LHCGR | | | | 0 | 0 |
LIFR | | | | 0 | 0 |
LIG3 | | | | 0 | 0 |
LIG4 | | | | 0 | 0 |
LIMK1 | | | | 0 | 0 |
LMO1 | | | | 0 | 0 |
LONRF3 | | | | 0 | 0 |
LPL | | | | 0 | 0 |
LPP | | | | 0 | 0 |
LRFN5 | | | | 0 | 0 |
LRIG3 | | | | 0 | 0 |
LRP1 | | | | 0 | 0 |
LRP1B | 多形性胶质母细胞瘤 | | 多柔比星, | 2 | 2 |
LRP2 | | | | 0 | 0 |
LRP4 | | | | 0 | 0 |
LRP5 | | | | 0 | 0 |
LRP6 | | | | 0 | 0 |
LRRC34 | | | | 0 | 0 |
LRRC4C | | | | 0 | 0 |
LRRC7 | | | | 0 | 0 |
LRRFIP2 | | | | 0 | 0 |
LRRIQ3 | | | | 0 | 0 |
LRRK1 | | | | 0 | 0 |
LRRK2 | | | | 0 | 0 |
LRRTM4 | | | | 0 | 0 |
LSMEM1 | | | | 0 | 0 |
LTK | | | | 0 | 0 |
LYN | 慢性髓系白血病 | 阿昔替尼,达沙替尼, | | 1 | 2 |
LYRM9 | | | | 0 | 0 |
LZTR1 | 神经鞘瘤病 | | | 1 | 1 |
LZTS1 | | | | 0 | 0 |
MACF1 | | | | 0 | 0 |
MAD1L1 | | | | 0 | 0 |
MAF | | | | 0 | 0 |
MAFB | | | | 0 | 0 |
MAGEH1 | 胆管腺癌 | | 吉西他滨, | 1 | 1 |
MAGI2 | | | | 0 | 0 |
MAGOH | | | | 0 | 0 |
MAGOHB | | | | 0 | 0 |
MALT1 | | | | 0 | 0 |
MAML1 | | | | 0 | 0 |
MAML2 | | | | 0 | 0 |
MAML3 | | | | 0 | 0 |
MAN1B1 | | | | 0 | 0 |
MAP2K1 | 结直肠癌,朗格汉斯细胞组织细胞增多症,肺腺癌,黑色素瘤,卵巢浆膜癌 | 西妥昔单抗,达拉非尼,司美替尼,曲美替尼,维莫非尼, | 伊立替康, | 11 | 15 |
MAP2K2 | 黑色素瘤 | 维莫非尼, | | 1 | 1 |
MAP2K3 | | | | 0 | 0 |
MAP2K4 | | | | 0 | 0 |
MAP2K7 | 肺癌 | | | 1 | 1 |
MAP3K1 | | | | 0 | 0 |
MAP3K13 | | | | 0 | 0 |
MAP3K14 | | | | 0 | 0 |
MAP3K4 | | | | 0 | 0 |
MAP4K1 | | | | 0 | 0 |
MAP4K3 | | | | 0 | 0 |
MAP4K5 | | | | 0 | 0 |
MAPK1 | 头颈鳞状细胞癌,非小细胞肺癌 | 厄洛替尼,WZ4002, | | 3 | 4 |
MAPK13 | | | | 0 | 0 |
MAPK14 | | | | 0 | 0 |
MAPK3 | | | | 0 | 0 |
MAPK8 | | | | 0 | 0 |
MAPK8IP1 | | | | 0 | 0 |
MAPK9 | | | | 0 | 0 |
MAPKAP1 | | | | 0 | 0 |
MAPKBP1 | | | | 0 | 0 |
MARK2 | | | | 0 | 0 |
MAX | | | | 0 | 0 |
MB21D2 | | | | 0 | 0 |
MBD4 | | | | 0 | 0 |
MC1R | | | | 0 | 0 |
MCC | | | | 0 | 0 |
MCL1 | | | | 0 | 0 |
MCM3 | | | | 0 | 0 |
MDC1 | | | | 0 | 0 |
MDH2 | | | | 0 | 0 |
MDM2 | 癌症,食道鳞状细胞癌,头颈癌,脂肪肉瘤,恶性胸膜间皮瘤 | MK-8242,派姆单抗(帕博利珠单抗),纳武单抗(纳武利尤单抗),伊匹单抗, | 顺铂,培美曲塞, | 4 | 6 |
MDM4 | 癌症 | 派姆单抗(帕博利珠单抗),纳武单抗(纳武利尤单抗),阿特朱单抗,阿替利珠单抗, | | 2 | 2 |
MECOM | | | | 0 | 0 |
MED12 | | | | 0 | 0 |
MED19 | | | | 0 | 0 |
MEF2B | | | | 0 | 0 |
MEF2C | | | | 0 | 0 |
MEIS1 | | | | 0 | 0 |
MEN1 | 甲状腺损伤细胞癌 | | | 1 | 1 |
MERTK | 黑色素瘤 | UNC1062, | | 1 | 1 |
MET | 癌症,结直肠癌,胃腺癌,多形胶质母细胞瘤,肺腺癌,非小细胞肺癌,肺鳞状细胞癌,乳头状肾细胞癌,皮肤黑色素瘤,胃癌,葡萄膜黑色素瘤 | Anti-EGFR Monoclonal Antibody,卡博替尼,卡马替尼,西妥昔单抗,克唑替尼,厄洛替尼,Foretinib,吉非替尼,MEK Inhibitor,MET Inhibition,ErbB3 Inhibition,Naquotinib,Onartuzumab,奥希替尼,Rilotumumab,沃利替尼,司美替尼,Tepotinib,曲美替尼,维莫非尼, | | 13 | 40 |
MGA | | | | 0 | 0 |
MGMT | 变性少突胶质瘤,多形胶质母细胞瘤,恶性胶质瘤,神经内分泌瘤,少突胶质瘤 | O(6)-benzylguanine,替莫唑胺, | 卡莫司汀,洛莫司汀, | 3 | 13 |
MIA2 | | | | 0 | 0 |
MIB1 | | | | 0 | 0 |
MIDN | | | | 0 | 0 |
MIEN1 | | | | 0 | 0 |
MIOS | | | | 0 | 0 |
MIPOL1 | | | | 0 | 0 |
MIR218-1 | 结直肠癌,胰腺癌 | | | 2 | 3 |
MITF | 黑色素瘤 | PLX4720,司美替尼, | | 1 | 1 |
MKI67 | 乳腺癌,前列腺癌 | | | 1 | 2 |
MKNK1 | | | | 0 | 0 |
MKNK2 | | | | 0 | 0 |
MKRN3 | | | | 0 | 0 |
MLH1 | 林奇综合征,胃癌 | | 奥沙利铂, | 28 | 28 |
MLH3 | | | | 0 | 0 |
MLL | | | | 0 | 0 |
MLL2 | | | | 0 | 0 |
MLL3 | | | | 0 | 0 |
MLLT1 | | | | 0 | 0 |
MLLT3 | | | | 0 | 0 |
mllt4 | | | | 0 | 0 |
MLLT6 | | | | 0 | 0 |
MLST8 | | | | 0 | 0 |
MMP11 | | | | 0 | 0 |
MMP12 | | | | 0 | 0 |
MMP14 | | | | 0 | 0 |
MMP16 | | | | 0 | 0 |
MMP2 | 脑胶质瘤,炎性乳腺癌 | 贝伐单抗, | | 1 | 2 |
MMP3 | | | | 0 | 0 |
MMP9 | 炎性乳腺癌 | 贝伐单抗, | | 1 | 1 |
MMS19 | | | | 0 | 0 |
MN1 | | | | 0 | 0 |
MNAT1 | | | | 0 | 0 |
MNDA | | | | 0 | 0 |
MNX1 | | | | 0 | 0 |
MOCS2 | | | | 0 | 0 |
MOV10L1 | | | | 0 | 0 |
MPL | 原发性血小板增多症,骨髓纤维化 | | | 2 | 2 |
MPO | | | | 0 | 0 |
MRE11 | | | | 0 | 0 |
MRE11A | 子宫内膜癌,前列腺癌 | 他拉唑帕尼,奥拉帕利, | | 2 | 2 |
MRPL19 | | | | 0 | 0 |
MS4A1 | | | | 0 | 0 |
MS4A3 | | | | 0 | 0 |
MSH2 | 林奇综合征,尿路上皮癌 | MEDI0680,MEDI4736, | | 7 | 7 |
MSH3 | | | | 0 | 0 |
MSH4 | | | | 0 | 0 |
MSH5 | | | | 0 | 0 |
MSH6 | 林奇综合征,尿路上皮癌 | MEDI0680,MEDI4736, | | 7 | 7 |
MSI1 | | | | 0 | 0 |
MSI2 | | | | 0 | 0 |
MSN | | | | 0 | 0 |
MSR1 | | | | 0 | 0 |
MST1 | | | | 0 | 0 |
MST1R | | | | 0 | 0 |
MTAP | 乳腺癌 | | 氟尿嘧啶, | 1 | 1 |
MTDH | | | | 0 | 0 |
MTF1 | | | | 0 | 0 |
MTHFD1 | | | | 0 | 0 |
MTHFR | 胰腺癌,直肠癌,胃癌 | | 氟尿嘧啶, | 1 | 3 |
MTMR3 | | | | 0 | 0 |
MTOR | 膀胱癌,乳腺癌,透明细胞肾细胞癌,子宫内膜腺癌,黑色素瘤,肾细胞癌,实体瘤,T细胞急性淋巴细胞白血病,甲状腺癌,尿路上皮癌 | Capivasertib,AZD8055,依维莫司,LY294002,MTOR Inhibitors,帕唑帕尼,培唑帕尼,RapaLink-1,西罗莫司, | 雷帕霉素, | 17 | 21 |
MTR | | | | 0 | 0 |
MTRR | | | | 0 | 0 |
MTUS1 | | | | 0 | 0 |
MUC1 | | | | 0 | 0 |
MUC16 | | | | 0 | 0 |
MUC5B | | | | 0 | 0 |
MUC6 | | | | 0 | 0 |
MUS81 | | | | 0 | 0 |
MUTYH | | | | 0 | 0 |